Haemostatic abnormalities in cats with naturally occurring liver diseases

Veterinary Journal

Volumn 193, Issue 1, 2012, Pages 103-108

  Dircks, Brigitte ^a   Nolte, Ingo ^a   Mischke, Reinhard ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

Cat; D dimers; Factor XIII; Haemostasis; Liver disease

Indexed keywords

ALPHA 2 ANTIPLASMIN; ANTITHROMBIN; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; D DIMER; FIBRINOGEN; PROTEIN C; PROTHROMBIN;

ARTICLE; BLOOD CLOTTING DISORDER; BLOOD CLOTTING FACTOR 13 DEFICIENCY; CAT; CONTROLLED STUDY; DEGENERATIVE DISEASE; HEPATITIS; LIPIDOSIS; LIVER DISEASE; LIVER HISTOLOGY; LIVER TUMOR; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME; THROMBIN TIME; THROMBOCYTE COUNT;

ANIMALS; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION TESTS; BLOOD PROTEINS; CAT DISEASES; CATS; FEMALE; GERMANY; HEMOSTATIC DISORDERS; LIVER DISEASES; MALE; PARTIAL THROMBOPLASTIN TIME; PLATELET COUNT; PROSPECTIVE STUDIES; PROTHROMBIN TIME;

EID: 84863779990     PISSN: 10900233     EISSN: 15322971     Source Type: Journal    
DOI: 10.1016/j.tvjl.2011.09.026     Document Type: Article

References (44)

1. Amitrano L., Guardascione M.A., Brancaccio V., Balzano A. Coagulation disorders in liver disease. Seminars in Liver Disease 2002, 22:83-96.
2. Boudreaux M.K., Weiss R.C., Cox N., Spano J.S. Evaluation of antithrombin-III activity as a coindicator of disseminated intravascular coagulation in cats with induced feline infectious peritonitis virus infection. American Journal of Veterinary Research 1989, 50:1910-1913.
3. Brazzell J.L., Borjesson D.L. Evaluation of plasma antithrombin activity and D-dimer concentration in populations of healthy cats, clinically ill cats, and cats with cardiomyopathy. Veterinary Clinical Pathology 2007, 36:79-83.
4. Burchhardt P., Tilsner V., Hupe W. Faktor XIII-Mangel als Ursache postoperativer Nachblutungen. Aktuelle Urologie 1978, 9:29-33.
5. Carr J.M., McKinney M., McDonagh J. Diagnosis of disseminated intravascular coagulation. Role of D-dimer. American Journal of Clinical Pathology 1986, 91:280-287.
6. Center S.A., Warner K., Corbett J., Randolph J.F., Erb H.N. Proteins invoked by vitamin K absence and clotting times in clinically ill cats. Journal of Veterinary Internal Medicine 2000, 14:292-297.
7. Ceron J.J., Eckersall P.D., Martýnez-Subiela S. Acute phase proteins in dogs and cats: Current knowledge and future perspectives. Veterinary Clinical Pathology 2005, 34:85-99.
8. Danese S., Vetrano S., Zhang L., Poplis V.A., Castellino F.J. The protein C pathway in tissue inflammation and injury: Pathogenic role and therapeutic implications. Blood 2010, 115:1121-1130.
9. Dunn M.E. Acquired coagulopathies. Textbook of Veterinary Internal Medicine 2009, 797-801. Saunders, St. Louis, USA. Seventh Ed. S.J. Ettinger, E.C. Feldman (Eds.).
10. Egbring R., Kröniger A., Seitz R. Factor XIII deficiency: Pathogenic mechanisms and clinical significance. Seminars in Thrombosis Hemostasis 1996, 22:419-425.
11. Esmon T.C. The protein C pathway. Chest 2003, 124:26S-32S.
12. Estrin M.A., Wehausen C.E., Jessen C.R., Lee J.A. Disseminated intravascular coagulation in cats. Journal of Veterinary Internal Medicine 2006, 20:1334-1339.
13. Francis C.W., Marder V.J. Rapid formation of large molecular weight alpha-polymers in cross-linked fibrin induced by high factor XIII concentrations Role of platelet factor XIII. Journal of Clinical Investigation 1987, 80:1459-1465.
14. Francis C.W., Marder V.J. Increased resistance to plasmic degradation of fibrin with highly crosslinked alpha-polymer chains formed at high factor XIII concentrations. Blood 1988, 71:1361-1365.
15. Gerlach R., Raabe A., Zimmermann M., Siegemund A., Seifert V. Factor XIII deficiency and postoperative hemorrhage after neurosurgical procedures. Surgical Neurology 2000, 54:260-266.
16. Gödje O., Haushofer M., Lamm P., Reichart B. The effect of factor XIII on bleeding in coronary surgery. The Thoracic and Cardiovascular Surgeon 1998, 46:263-267.
17. Greenberg C.S., Miraglia C.C., Rickles F.R., Shuman M.A. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting. The Journal of Clinical Investigation 1985, 75:1463-1470.
18. Gürsoy S., Başkol M., Torun E., Yurci A., Soyuer I., Eser B., Güven K., Ozbakir O., Yücesoy M. Importance of anticoagulant proteins in chronic liver diseases. The Turkish Journal of Gastroenterology 2005, 16:129-133.
19. Hedner U., Henriksson P., Nilsson I.M. Factor XIII in a clinical material. Scandinavian Journal of Haematology 1975, 14:114-119.
20. Jacobsson K. Studies on fibrinogen: I. Studies on the determination of fibrinogen in human blood plasma. Scandinavian Journal of Clinical and Laboratory Investigation 1955, 7:1-54.
21. Kruskal J.B., Robson S.C., Franks J.J., Kirsch R.E. Elevated fibrin-related and fibrinogen-related antigens in patients with liver disease. Hepatology 1992, 16:920-923.
22. Liaw P.C., Esmon C.T., Kahnamoui K., Schmidt S., Kahnamoui S., Ferrell G., Beaudin S., Julian J.A., Weitz J.I., Crowther M., Loeb M., Cook D. Patients with severe sepsis vary markedly in their ability to generate activated protein C. Blood 2004, 104:3958-3964.
23. Lisciandro S.C., Hohenhaus A., Brooks M. Coagulation abnormalities in 22 cats with naturally occurring liver disease. Journal of Veterinary Internal Medicine 1998, 12:71-75.
24. Lisman T., Leebeek F.W. Hemostatic alterations in liver disease: A review on pathophysiology, clinical consequences, and treatment. Digestive Surgery 2007, 24:250-258.
25. Mammen E.F. Coagulopathies of liver disease. Clinics in Laboratory Medicine 1994, 14:769-780.
26. Mischke R. Acute haemostatic changes in accidentally traumatised dogs. The Veterinary Journal 2005, 169:60-64.
27. Mischke R., Deniz A., Nolte I. Optimized methods for measuring coagulation factors II, IV, VII and X in cats. Deutsche Tierärztliche Wochenschrift 1994, 101:430-433.
28. Mischke R., Deniz A., Nolte I. Influence of sample predilution on the sensitivity of prothrombin time in feline plasma. Zentralblatt für Veterinärmedizin A 1996, 43:155-162.
29. Mischke R., Pöhle D., Schoon H.A., Fehr M., Nolte I. Alterations of hemostasis in liver cirrhosis of the dog. Deutsche Tierärztliche Wochenschrift 1998, 105:43-47.
30. Miyake Y., Iwasaki Y., Makino Y., Kobashi H., Takaguchi K., Ando M., Sakaguchi K., Shiratori Y. Prognostic factors for fatal outcomes prior to receiving liver transplantation in patients with non-acetaminophen-related fulminant hepatic failure. Journal of Gastroenterology and Hepatology 2007, 22:855-861.
31. Nicolaes G.A., Tans G., Thomassen M.C., Hemker H.C., Pabinger I., Varadi K., Schwarz H.P., Rosing J. Peptide bond cleavages and loss of functional activity during inactivation of factor Va and factor VaR506Q by activated protein C. The Journal of Biological Chemistry 1995, 270:21158-21166.
32. Nussbaum M., Morse B.S. Plasma fibrin stabilizing factor activity in various diseases. Blood 1964, 23:69-77.
33. Ogura H., Gando S., Iba T., Eguchi Y., Ohtomo Y., Okamoto K., Koseki K., Mayumi T., Murata A., Ikeda T., Ishikura H., Ueyama M., Kushimoto S., Saitoh D., Endo S., Shimazaki S. SIRS-associated coagulopathy and organ dysfunction in critically ill patients with thrombocytopenia. Shock 2007, 28:411-417. Japanese Association for Acute Medicine Disseminated Intravascular Coagulation Study Group.
34. Prins M., Schellens C.J., van Leeuwen M.W., Rothuizen J., Teske E. Coagulation disorders in dogs with hepatic disease. The Veterinary Journal 2010, 185:163-168.
35. Risberg B.O., Medegard A., Heideman M., Gyzander E., Bundsen P., Oden M., Teger-Nilsson A.N. Early activation of humoral proteolytic systems in patients with multiple trauma. Critical Care Medicine 1986, 14:917-925.
36. Sakata Y., Aoki N. Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor. Journal of Clinical Investigation 1980, 65:290-297.
37. Song J.W., Choi J.R., Song K.S., Rhee J.H. Plasma factor XIII activity in patients with disseminated intravascular coagulation. Yonsei Medical Journal 2006, 47:196-200.
38. Tacke F., Fiedler K., von Depka M., Luedde T., Hecker H., Manns M.P., Ganser A., Trautwein C. Clinical and prognostic role of plasma coagulation factor XIII activity for bleeding disorders and 6-year survival in patients with chronic liver disease. Liver International 2006, 26:173-181.
39. Thachil J. Relevance of clotting tests in liver disease. Postgraduate Medical Journal 2008, 84:177-181.
40. Tholen I., Weingart C., Kohn B. Concentration of D-dimers in healthy cats and sick cats with and without disseminated intravascular coagulation (DIC). Journal of Feline Medicine and Surgery 2009, 11:842-846.
41. Thomas J.S., Green R.A. Clotting times and antithrombin III activity in cats with naturally developing diseases: 85 cases (1984-1994). Journal of the American Veterinary Medical Association 1998, 213:1290-1295.
42. Ueyama M., Maruyama I., Osame M., Sawada Y. Marked increase in plasma interleukin-6 in burn patients. Journal of Laboratory and Clinical Medicine 1992, 120:693-698.
43. Weiss D.J., Moritz A. Liver cytology. Veterinary Clinics of North America: Small Animal Practice 2002, 32:1267-1291.
44. Weiss R.C., Dodds W.J., Scott F.W. Disseminated intravascular coagulation in experimentally induced feline infectious peritonitis. American Journal of Veterinary Research 1980, 41:663-671.